| scholarly article | Q13442814 |
| P50 | author | Debra Hickman | Q89223538 |
| Mythily Srinivasan | Q80019884 | ||
| P2093 | author name string | Debomoy K Lahiri | |
| Emily Witek | |||
| Anish Thyagarajan | |||
| Niloy Lahiri | |||
| P2860 | cites work | Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration | Q24614960 |
| Rodent models of neuroinflammation for Alzheimer's disease | Q26864804 | ||
| Drug development in Alzheimer's disease: the path to 2025 | Q27007748 | ||
| Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease | Q28074504 | ||
| NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production | Q28196676 | ||
| The delta sleep inducing peptide (DSIP). Comparative properties of the original and synthetic nonapeptide | Q28278573 | ||
| Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators | Q28299369 | ||
| Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta | Q28581717 | ||
| A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death | Q28594815 | ||
| Recognition of proline-rich motifs by protein-protein-interaction domains | Q33214804 | ||
| Quantitative tissue-specific dynamics of in vivo GILZ mRNA expression and regulation by endogenous and exogenous glucocorticoids | Q34479809 | ||
| Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition | Q35087794 | ||
| Novel p65 binding glucocorticoid-induced leucine zipper peptide suppresses experimental autoimmune encephalomyelitis | Q35639706 | ||
| Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease | Q36092100 | ||
| Rodent models for Alzheimer's disease drug discovery. | Q36117249 | ||
| Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice | Q36241433 | ||
| NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease | Q36632979 | ||
| Role of nuclear factor kappaB in the central nervous system. | Q36766309 | ||
| LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals | Q36781712 | ||
| Peptide inhibitors of beta-amyloid aggregation. | Q36929769 | ||
| Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy | Q37010500 | ||
| Cell-penetrating peptides: from molecular mechanisms to therapeutics. | Q37110276 | ||
| Regulation of the RelA (p65) transactivation domain | Q37217743 | ||
| Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. | Q37536467 | ||
| Acetaminophen attenuates lipopolysaccharide-induced cognitive impairment through antioxidant activity | Q37597304 | ||
| Strategic approaches to optimizing peptide ADME properties | Q38264736 | ||
| Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis | Q38344541 | ||
| The Role of Neuroinflammation in Age-Related Dementias | Q38793655 | ||
| Nuclear factor-κB regulates βAPP and β- and γ-secretases differently at physiological and supraphysiological Aβ concentrations | Q39338754 | ||
| NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. | Q40014779 | ||
| Glucocorticoid-induced leucine zipper (GILZ)/NF-kappaB interaction: role of GILZ homo-dimerization and C-terminal domain. | Q40196251 | ||
| NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells | Q40422672 | ||
| NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. | Q40437194 | ||
| Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module | Q41431634 | ||
| Proline rich motifs as drug targets in immune mediated disorders | Q42124413 | ||
| Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease | Q42134488 | ||
| Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease | Q42447369 | ||
| Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease | Q42452339 | ||
| Alzheimer's disease drug development pipeline: 2017. | Q42655757 | ||
| BACE1 mRNA Expression in Alzheimer's Disease Postmortem Brain Tissue | Q42866948 | ||
| GILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoids | Q42940793 | ||
| Properties of polyproline II, a secondary structure element implicated in protein-protein interactions | Q45229454 | ||
| Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice. | Q46088882 | ||
| SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling | Q46218230 | ||
| Possible role of resveratrol targeting estradiol and neprilysin pathways in lipopolysaccharide model of Alzheimer disease | Q46525640 | ||
| Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties | Q46928060 | ||
| A novel 77-residue peptide from porcine brain contains a leucine-zipper motif and is recognized by an antiserum to delta-sleep-inducing peptide | Q48102991 | ||
| FLZ attenuates learning and memory deficits via suppressing neuroinflammation induced by LPS in mice | Q48360185 | ||
| Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. | Q48369204 | ||
| Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease | Q48912994 | ||
| Delta sleep-inducing peptide (DSIP)-like immunoreactivity in gut: coexistence with known peptide hormones | Q48948956 | ||
| Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. | Q52608158 | ||
| Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E. | Q53341448 | ||
| Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation | Q72724356 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| pathology | Q7208 | ||
| P304 | page(s) | 488-498 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Alzheimer's & dementia (New York, N. Y.) | Q27726239 |
| P1476 | title | Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model | |
| P478 | volume | 4 |
| Q92969001 | Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models | cites work | P2860 |
Search more.